Large vessel occlusion stroke due to intracranial atherosclerotic disease: identification, medical and interventional treatment, and outcomes
A De Havenon, OO Zaidat, S Amin-Hanjani… - Stroke, 2023 - Am Heart Assoc
Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-
LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …
LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …
Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial
B Jia, X Zhang, N Ma, D Mo, F Gao, X Sun… - JAMA …, 2022 - jamanetwork.com
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …
Novel CH25H+ and OASL+ microglia subclusters play distinct roles in cerebral ischemic stroke
Y Zhang, Y Guo, R Li, T Huang, Y Li, W Xie… - Journal of …, 2023 - Springer
Background Microglial polarization is one of the most promising therapeutic targets for
multiple central nervous system (CNS) disorders, including ischemic stroke. However …
multiple central nervous system (CNS) disorders, including ischemic stroke. However …
Dual antiplatelet therapy using cilostazol in patients with stroke and intracranial arterial stenosis
S Uchiyama, K Toyoda, K Omae, R Saita… - Journal of the …, 2021 - Am Heart Assoc
Background Long‐term benefit of dual antiplatelet therapy (DAPT) over single antiplatelet
therapy (SAPT) for the prevention of recurrent stroke has not been established in patients …
therapy (SAPT) for the prevention of recurrent stroke has not been established in patients …
Imaging Parameters Predict Recurrence After Transient Ischemic Attack or Minor Stroke Stratified by ABCD2 Score
J Jing, Y Suo, A Wang, Y Zuo, Y Jiang, L Liu, X Zhao… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: Whether imaging parameters would independently predict stroke
recurrence in low-risk minor ischemic stroke (MIS) or transient ischemic attack (TIA) …
recurrence in low-risk minor ischemic stroke (MIS) or transient ischemic attack (TIA) …
Fibrinolysis and remote ischemic conditioning: mechanisms and treatment perspectives in stroke
AE Krag, RA Blauenfeldt - Seminars in Thrombosis and …, 2021 - thieme-connect.com
Stroke is a leading cause of death and disability. Intravenous thrombolysis and mechanical
thrombectomy have greatly improved outcomes in acute ischemic stroke (AIS). However …
thrombectomy have greatly improved outcomes in acute ischemic stroke (AIS). However …
Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis
T Ueda, S Takaishi, T Yoshie, N Usuki, K Tatsuno… - BMC neurology, 2022 - Springer
Background The optimal treatment for intracranial artery stenosis (ICAS) has not been
established. We retrospectively examined the initial and long-term outcomes associated with …
established. We retrospectively examined the initial and long-term outcomes associated with …
Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE‐2
C Wang, W Jia, J Jing, X Meng, A Wang… - Journal of the …, 2023 - Am Heart Assoc
Background This study aimed to investigate the efficacy and safety of ticagrelor–aspirin
versus clopidogrel–aspirin in Chinese patients by the presence and clinical presentation of …
versus clopidogrel–aspirin in Chinese patients by the presence and clinical presentation of …
Immune Markers Are Associated With Asymptomatic Intracranial Large Artery Stenosis and Future Vascular Events in NOMAS
BACKGROUND: Inflammation contributes to atherosclerosis but is incompletely
characterized in intracranial large artery stenosis (ICAS). We hypothesized that immune …
characterized in intracranial large artery stenosis (ICAS). We hypothesized that immune …
[HTML][HTML] Патогенетические механизмы ишемического инсульта: от верификации до вторичной профилактики
АА Кулеш, ДА Демин, ОИ Виноградов - Consilium Medicum, 2021 - cyberleninka.ru
Ишемический инсульт представляет собой чрезвычайно гетерогенное заболевание:
существует более 200 причин мозговой катастрофы. Раннее установление …
существует более 200 причин мозговой катастрофы. Раннее установление …